Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 109, 2001 - Issue 4
13
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A Model for Regulation of the Mg2+-Stimulated Acto-Myosin-ATPase Activity: Inhibition of the Formation of Actin-Myosin Complex and the Mg2+-Stimulated Acto-Myosin-ATPase Activity by IMP and AMP

, , , &
Pages 316-322 | Published online: 03 Oct 2008
 

Abstract

Previously, we showed that the decrease in force output during continuous isometric contractions in rat skeletal muscle was related to an increase in the concentration of IMP. In this paper we report on additional experiments in which the effect of IMP on the Mg 2+ -stimulated acto-myosin-ATPase activity of isolated actin and myosin is measured at 35°C. The results show that 1) the binding of actin to myosin is co-operative (Hill coefficient = 3.82); 2) in the presence of IMP or AMP the Mg 2+ -stimulated acto-myosin-ATPase activity is inhibited up to 60% at 10 mM; 3) in the presence of IMP or AMP not only the Mg 2+ -stimulated acto-myosin-ATPase activity decreases, but also K 50. From these results we conclude that IMP and AMP may be considered as uncompetitive inhibitors. Our results suggest that IMP and AMP can prevent an ‘energy crisis’ during exhaustive exercise of short duration by down-regulating the contractile machinery.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.